| Bacillus anthracis |
Anthrax lethal factor |
Potency |
12.6 |
nM |
None |
| Cryptosporidium parvum |
Cryptosporidium parvum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-galactosidase A |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Alpha-galactosidase A |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Arachidonate 12-lipoxygenase |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
398.1 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
631.0 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
1584.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
794.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
631.0 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
1584.9 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Guanine nucleotide-binding protein G(i) subunit alpha-1/Regulator of G-protein signaling 12 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Vdss |
2.84 |
L.kg-1 |
10.1016/j.ejmech.2009.06.004 |
| Homo sapiens |
Hydroxycarboxylic acid receptor 2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 |
Inhibition |
2.0 |
% |
10.1016/j.bmcl.2015.09.034 |
| Homo sapiens |
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 |
Inhibition |
13.0 |
% |
10.1016/j.bmcl.2015.09.034 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pyruvate kinase isozymes M1/M2 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
1624.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thrombopoietin |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
125.9 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Whole blood |
Retention_time |
2.28 |
min |
10.1007/s00044-012-9977-1 |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania infantum |
Leishmania infantum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania major |
Leishmania major |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania mexicana |
Leishmania mexicana |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania mexicana |
Pyruvate kinase |
Potency |
10000.0 |
nM |
None |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
39810.7 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Pneumocystis carinii |
Pneumocystis carinii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Plasma |
logFu |
1.0 |
None |
10.1016/j.ejmech.2009.06.004 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Toxoplasma gondii |
Toxoplasma gondii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| None |
NON-PROTEIN TARGET |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| None |
No relevant target |
log K |
0.13 |
None |
10.1021/jm9003945 |
| None |
No relevant target |
log K |
0.59 |
None |
10.1021/jm9003945 |
| None |
No relevant target |
LogP |
0.89 |
None |
10.1021/jm9003945 |
| None |
No relevant target |
pKa |
9.86 |
None |
10.1016/j.ejmech.2009.06.004 |
| None |
No relevant target |
pKa |
10.25 |
None |
10.1021/jm9003945 |
| None |
No relevant target |
solubility |
nan |
None |
10.1016/j.bmc.2010.08.003 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |